首页> 外文期刊>Oncology research and treatment. >A Rare Case of Mixed Adenoneuroendocrine Carcinoma (MANEC) of the Gastroesophageal Junction with HER2/neu Overexpression and Distinct Orbital and Optic Nerve Toxicity after Intravenous Administration of Cisplatin
【24h】

A Rare Case of Mixed Adenoneuroendocrine Carcinoma (MANEC) of the Gastroesophageal Junction with HER2/neu Overexpression and Distinct Orbital and Optic Nerve Toxicity after Intravenous Administration of Cisplatin

机译:一种罕见的混合腺嘌呤内分泌癌(Manec)胃肠道交界处与HER2 / Neu过表达和静脉施用后静脉施用后的不同轨道和视神经毒性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Mixed adenoneuroendocrine carcinomas (MANECs) are rare malignancies with both neuroendocrine and non-neuroendocrine components. To date, the prognosis of gastroenteropancreatic MANECs remains dismal, and treatment options are mainly based on guidelines for the treatment of pure neuroendocrine carcinomas or small cell lung cancer. Established first-line therapy in the metastatic situation is cisplatin and etoposide. Platinum derivatives are known to cause a variety of side effects also involving the visual system. Severe orbital and optic nerve toxicities have been described mainly after intracarotid infusion of cisplatin. Case Report: Herein we report a rare case of a 60-year-old male patient suffering from MANEC of the gastroesophageal junction with HER2/neu overexpression who developed severe orbital and ocular neurotoxicity (grade 3 according to CTCAE v4.03) after intravenous cisplatin. Conclusion: We discuss diagnostic approaches and differential diagnoses in this clinical situation. Before starting treatment with intravenous and topical steroids, it is crucial to rule out meningeal and cerebral spread as well as paraneoplastic and endocrine syndromes. (c) 2019 S. Karger AG, Basel
机译:背景:混合腺嘌呤内分泌癌(Manecs)是具有神经内分泌和非神经内分泌成分的罕见恶性肿瘤。迄今为止,胃肠甘露甘露植物的预后仍然是令人沮丧的,治疗方案主要基于治疗纯神经内分泌癌或小细胞肺癌的准则。在转移性情况下建立的一线治疗是顺铂和依托泊苷。已知铂衍生物引起各种副作用,也涉及视觉系统。在顺铂孵化后,主要描述了严重的眶和视神经毒性。案例报告:本文报告了罕见的患有60岁的男性患者,患有Her2 / Neu过表达患有Her2 / Neu过度表达的60岁的男性患者,他在静脉内顺铂之后开发了严重的眶下和眼神经毒性(根据CTCAE V4.03的3级) 。结论:我们讨论该临床情况下的诊断方法和差异诊断。在用静脉内和局部类固醇开始治疗之前,这对于排除脑膜和脑扩散以及平原和内分泌综合征至关重要。 (c)2019年S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号